AACR and Kure It Partner to Offer a New Grant for Kidney Cancer Research
Grant nominations are now open: Deadline is Tuesday, August 21, 2012.
PHILADELPHIA — The American Association for Cancer Research is pleased to announce a new partnership with Kure It and a call for nominations for the 2012 AACR-Kure It Grant for Kidney Cancer Research.
This two-year grant represents a joint effort to promote and support innovative kidney cancer research. The grant will support a translational research project designed to improve the survival and quality of life of patients with kidney cancer and, in turn, lead to individualized therapeutic options for the treatment or development of promising new kidney cancer therapies.
The grant recipient will receive $250,000 over the grant term (a two-year period) and complimentary registration to the AACR Annual Meeting 2013, to be held April 6-10 in Washington, D.C., where the recipient will be recognized.
Independent investigators are invited to submit proposals to develop and study new ideas and approaches that will have a direct application and relevance to patients with kidney cancer. The grant recipient will be selected by an expert scientific review committee of kidney cancer specialists assembled by the AACR.
The application deadline for the 2012 AACR-Kure It Grant for Kidney Cancer Research is at noon ET on Tuesday, Aug. 21, 2012.
The American Association for Cancer Research and Kure It are committed to sustaining the grant in a collaborative fashion to award research funding to the most promising kidney cancer research project. Learn more about the program guidelines and application eligibility criteria.
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR’s membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.
About Kure It
Kure It is a non-profit organization whose mission is to raise money for cancer research specialists conducting innovative projects to better treat and ultimately cure kidney cancer and other underfunded malignancies. Kure It has raised over $1 million for research since being founded in 2007. Kure It supports research at major institutions, including Samuel Oschin Cancer Center at Cedars Sinai; Beckman Research Institute at the City of Hope; and Knight Research Institute at Oregon Health Sciences University.